Prader-Willi Syndrome clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Sorry, in progress, not accepting new patients
This is a multi-center, multi-period study with an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period evaluating the safety and efficacy of DCCR treatment.
Orange, California and other locations

Last updated: November 18, 2022